Mct
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
462 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 7 | — | — | 1 | 14 | 22 |
| Fibrosis | D005355 | — | — | 10 | 4 | — | 1 | 6 | 21 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | 10 | 4 | — | 1 | 6 | 21 |
| Asthma | D001249 | EFO_0000270 | J45 | 2 | 1 | — | 1 | 8 | 12 |
| Premature birth | D047928 | EFO_0003917 | O60 | 1 | 1 | 1 | 2 | 7 | 12 |
| Psychotic disorders | D011618 | — | F20.81 | — | — | 1 | 1 | 10 | 12 |
| Mental disorders | D001523 | EFO_0000677 | F91.9 | — | — | 1 | 1 | 10 | 12 |
| Inflammation | D007249 | MP_0001845 | — | 1 | 2 | 1 | 1 | 7 | 11 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | 1 | 2 | 4 | 2 | 8 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | — | — | 1 | 5 | 7 |
Show 55 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Depression | D003863 | — | F33.9 | — | — | 1 | — | 19 | 20 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 1 | 3 | 1 | — | 13 | 17 |
| Schizophrenia | D012559 | EFO_0000692 | F20 | 1 | — | 1 | — | 14 | 16 |
| Depressive disorder | D003866 | EFO_1002014 | F32.A | — | — | 1 | — | 12 | 13 |
| Heart failure | D006333 | HP_0001635 | I50 | — | — | 1 | — | 6 | 7 |
| Covid-19 | D000086382 | — | — | — | 1 | 3 | — | 2 | 5 |
| Infections | D007239 | EFO_0000544 | — | — | — | 2 | — | 3 | 5 |
| Sclerosis | D012598 | — | — | — | 1 | 1 | — | 2 | 4 |
| Schizophrenia spectrum and other psychotic disorders | D019967 | — | — | — | — | 1 | — | 3 | 4 |
| Social phobia | D000072861 | EFO_1001917 | F40.1 | — | 1 | 1 | — | 1 | 3 |
Show 36 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | 3 | — | — | 9 | 12 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | 2 | — | — | 10 | 12 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 2 | 1 | — | — | 7 | 10 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 2 | 2 | — | — | 7 | 9 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 1 | 1 | — | — | 8 | 9 |
| Neoplasms | D009369 | — | C80 | 3 | 3 | — | — | 4 | 8 |
| Syndrome | D013577 | — | — | 3 | 3 | — | — | 3 | 7 |
| Overweight | D050177 | — | E66.3 | — | 1 | — | — | 5 | 6 |
| Wounds and injuries | D014947 | — | T14.8 | 1 | 1 | — | — | 4 | 6 |
| Exercise | D015444 | EFO_0000483 | — | — | 1 | — | — | 4 | 5 |
Show 60 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ketosis | D007662 | HP_0002919 | R82.4 | 1 | — | — | — | 5 | 6 |
| Ciliary motility disorders | D002925 | EFO_0003900 | — | 2 | — | — | — | 3 | 5 |
| Obstructive lung diseases | D008173 | HP_0006536 | — | 1 | — | — | — | 3 | 4 |
| Traumatic brain injuries | D000070642 | — | S06 | 1 | — | — | — | 3 | 4 |
| Brain injuries | D001930 | — | S06.9 | 1 | — | — | — | 3 | 4 |
| Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | 1 | — | — | — | 3 | 4 |
| Dyskinesias | D020820 | HP_0002310 | G24 | 2 | — | — | — | 2 | 4 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | — | — | — | 2 | 3 |
| Traumatic stress disorders | D040921 | — | — | 1 | — | — | — | 2 | 3 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 1 | — | — | — | 1 | 2 |
Show 18 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Epilepsy | D004827 | EFO_0000474 | G40.9 | — | — | — | — | 7 | 7 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | — | — | — | 5 | 5 |
| Ketogenic diet | D055423 | — | — | — | — | — | — | 5 | 5 |
| Allergic rhinitis | D065631 | — | J30.9 | — | — | — | — | 4 | 4 |
| Rhinitis | D012220 | EFO_0008521 | J31 | — | — | — | — | 4 | 4 |
| Liver diseases | D008107 | HP_0002910 | K70-K77 | — | — | — | — | 4 | 4 |
| Bronchiolitis | D001988 | HP_0011950 | — | — | — | — | — | 4 | 4 |
| Neurodevelopmental disorders | D065886 | — | F89 | — | — | — | — | 3 | 3 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | — | 3 | 3 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | — | — | — | — | 3 | 3 |
Show 189 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use